Evidence Hub

Comparison of Early Changes in Ocular Surface and Inflammatory Mediators Among Lenticule Extraction, Laser in Situ Keratomileusis and Femtosecond Laser-assisted Laser in Situ Keratomileusis

ClinicalTrials.gov · COMPLETED, 2016

75 participants

Abstract

To evaluate the short-term changes in ocular surface measures and tear inflammatory mediators after lenticule extraction (FLEx), laser in situ keratomileusis (LASIK) and femtosecond laser-assisted laser in situ keratomileusis (FS-LASIK) procedures.

Conditions: Myopia, Astigmatism.

Primary outcome: scale of Schirmer I test; scale of corneal fluorescein staining; scale of noninvasive tear breakup time; questionnaire of ocular surface disease index; scale of central corneal sensitivity; scale of tear meniscus height; concentration of Interleukin-1α; concentration of tumor necrosis factor-α; concentration of nerve growth factor; interferon-γ; concentration of transforming growth factor-β1; concentration of matrix metalloproteinase-9.

Enrollment: 75 participants.

How strong is the evidence?

Evidence Hub reads this as a clinical trial, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 75 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free